Search

Search

このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

ホーム
...
研究分野生物医学と臨床科学心血管医学と血液学心臓病 (心血管疾患を含む)
肝炎 D: レビュー

肝炎 D: レビュー

Francesco Negro ¹, Anna S Lok ²

Francesco Negro ¹, Anna S Lok ²

¹Division of Gastroenterology and Hepatology, Geneva University Hospitals, Geneva, Switzerland.
²Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor.

⁰Division of Gastroenterology and Hepatology, Geneva University Hospitals, Geneva, Switzerland.

Jama +

|

2023年11月9日

関連する実験動画

These videos have been matched automatically. Contact us if they are not relevant.

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

See all related videos

PubMedで要約を見る

まとめ

この要約は機械生成です。

肝炎Dウイルス (HDV) 感染は,しばしば肝炎Bウイルス (HBV) で発生し,肝疾患の進行を加速します. ブレヴァルチドのような新しい治療法は臨床試験でこの重要な世界的な健康問題に対処する可能性を示しています

科学分野

肝病学とウイルス学
感染症
胃腸内科

背景

肝炎Dウイルス (HDV) と肝炎Bウイルス (HBV) の共感染は,世界中で何百万人に感染し,肝硬変や肝細胞癌を含むより重度の肝疾患を引き起こす.
慢性 HBV 感染者における HDV 超感染は,肝硬変と死亡率の高度の急速な進行を伴うが,疾患の進行は変動する可能性がある.

結論

HDVは,その攻撃的な性質と重度の肝臓合併症と関連しているため,世界的な健康上の負担を大きくします.
アルファインターフェロンはある程度の効果があるが,副作用は一般的であり,HBVを標的とした治療はHDVに対して無効である.
ブレヴァルチドのような新興治療は,慢性HDV感染の管理における重要な進歩であり,治療戦略を最適化するための研究が進行中です.

関連する実験動画

自動的に一致したビデオです Contact us もしそれらが関連していない場合

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

See all related videos

関連する概念動画

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies